Luc Girard

Michael Peyton, John D. Minna, Veerabhadran Baladandayuthapani, 2012, Proceedings 2012 IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS).

Synthetic lethal screen identification of chemosensitizer loci in cancer cells

Michael Peyton, John D. Minna, Luc Girard, 2007, Nature.

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.

Luc Girard, John D Minna, J. Minna, 2016, Cell reports.

Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia

John D. Minna, John M. Maris, Victor E. Velculescu, 2004, Cancer Research.

Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non–Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway

John D. Minna, Jaime Rodriguez-Canales, Chunli Shao, 2014, Clinical Cancer Research.

Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.

Yang Xie, John K Field, Luc Girard, 2008, Cancer research.

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.

Kenneth H Buetow, James W Jacobson, Kevin K Dobbin, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers.

Luc Girard, Maria P Wong, John D Minna, 2007, Cancer research.

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

Luc Girard, Matthew Meyerson, Xiaojun Zhao, 2004, Cancer research.

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

Michael Peyton, Li Shen, John N Weinstein, 2012, Cancer discovery.

The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.

John V Heymach, Luc Girard, Cheng-Ming Chiang, 2012, Cancer research.

Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung

John D. Minna, Humam Kadara, Yang Xie, 2010, PloS one.

Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5

Jaime Rodriguez-Canales, Chunli Shao, Hui Tian, 2015, Molecular Cancer Research.

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines

David C Christiani, Cheng Li, Luc Girard, 2004, Oncogene.

Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer

John D. Minna, Guanghua Xiao, Yang Xie, 2010, PLoS medicine.

Use of proteomic analysis of LKB1/AMPK/mTOR pathways to identify IGF-1R pathway upregulation with LKB1 loss or mTOR inhibition in NSCLC: Implications for targeted combinations.

John D. Minna, Kevin R. Coombes, Lixia Diao, 2012 .

Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

Michael Peyton, John D. Minna, Lixia Diao, 2013, Clinical Cancer Research.

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Laura Tolosi, Michael Peyton, Thomas Zander, 2009, The Journal of clinical investigation.

An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer

Jaime Rodriguez-Canales, Yang Xie, Luc Girard, 2016, Clinical Cancer Research.

A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene

Luc Girard, Jun Yokota, Takashi Kohno, 2010, Genes, chromosomes & cancer.

Seizure 6-like (SEZ6L) gene and risk for lung cancer.

John K Field, Stefan Kammerer, Luc Girard, 2007, Cancer research.

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Tao Wang, Yang Xie, Chunli Shao, 2014, Proceedings of the National Academy of Sciences.

Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small‐cell lung cancer cell lines

Calum MacAulay, Luc Girard, Bradley P. Coe, 2006, Genes, chromosomes & cancer.

MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs

Alexander Pertsemlidis, Luc Girard, John D Minna, 2010, Journal of experimental & clinical cancer research : CR.

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

John D. Minna, Tina Hernandez-Boussard, Jonathan R. Pollack, 2009, PloS one.

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers

Michael Q. Zhang, Yang Xie, Xiaotu Ma, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

John D. Minna, Tina Hernandez-Boussard, Jonathan R. Pollack, 2010 .

Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer

Luc Girard, Mitsuo Sato, J. Minna, 2003, Oncogene.

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.

Michael Peyton, Pierre P Massion, Luc Girard, 2005, Cancer research.

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Michael Peyton, John D. Minna, Li Shen, 2012, Clinical Cancer Research.

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

Luc Girard, Suzie K. Hight, Dhruba Deb, 2016, The Journal of clinical investigation.

Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.

Luc Girard, John D Minna, D. Fishman, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.